CAAS Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-172	Closed	-$216K	–	267
2023 Q2	$216K	Buy	172 +9	+6%	+$11.3K	0.01%	121
2023 Q1	$201K	Buy	+163	New	+$201K	0.01%	182